Latest News and Press Releases
Want to stay updated on the latest news?
-
The case alleges Navan failed to disclose it would increase its sales and marketing expenses by 39% just months after the IPO.
-
The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.
-
The case alleges Stellantis overstated its ability to capitalize on the electrification market.
-
The case alleges Babcock & Wilcox made false and/or misleading statements about the Power Generation Contract.
-
Robbins Geller is investigating whether Via Transportation and certain of its top executives made materially false and/or misleading statements to investor
-
The case alleges ImmunityBio materially overstated Anktiva’s capabilities.
-
The Eos Energy complaint alleges that Eos Energy was unable to achieve the ramp in production and capacity utilization required to achieve guidance.
-
The case alleges Stellantis overstated its ability to capitalize on the electrification market.
-
The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.
-
The case alleges that NuScale failed to disclose that it entrusted its NPM commercialization to an entity that lacked significant prior experience.